How effective are monoclonal antibodies at improving overall survival?
ASPIRE update: promising results for MM
Determining the progression of SMM using predictive biomarkers
Results of the Phase III DASISION trial and the future of CML treatment
An E-learning tool for hematology-oncology nurses